Overview An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis Status: Completed Trial end date: 2019-09-19 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the Safety and Efficacy of FB825 in Adults with Atopic Dermatitis Phase: Phase 2 Details Lead Sponsor: Fountain Biopharma Inc.